Background and purpose: Transient receptor potential melastatin 2 (TRPM2) is a non-selective Ca 2 þ -permeable cation channel and is known to be activated by adenosine 5 0 -diphosphoribose (ADP-ribose) and hydrogen peroxide. TRPM2 current responses are reported to be drastically potentiated by the combination of each of these ligands with heat. Furthermore, the combination of cyclic ADP-ribose with heat also activates TRPM2. Although flufenamic acid, antifungal agents (miconazole and clotrimazole), and a phospholipase A 2 inhibitor (N-(p-amylcinnamoyl)anthranilic acid) inhibit TRPM2, their inhibition was either gradual or irreversible. Experimental approach: To facilitate future research on TRPM2, we screened several compounds to investigate their potential to activate or inhibit the TRPM2 channels using the patch-clamp technique in HEK293 cells, transfected with human TRPM2. Key results: 2-aminoethoxydiphenyl borate (2-APB) exhibited a rapid and reversible inhibition of TRPM2 channels that had been activated by its ADP-ribose or cADP-ribose and heat in a dose-dependent manner (IC 50 about 1 mM). 2-APB also inhibited heat-evoked insulin release from pancreatic islets, isolated from rats. Conclusions and implications: 2-APB proved to be a powerful and effective tool for studying the function of TRPM2.
Introduction
The transient receptor potential (TRP) superfamily of ion channels in mammals comprises the following six subfamilies: TRPC (canonical or classical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPP (polycystin) and TRPML (mucolipin) (Clapham, 2003) . Among them, to date, nine channels have been reported to be thermosensitive (Bandell et al., 2007) . The capsaicin receptor (TRPV1) is the bestknown thermosensitive TRP channel, and many specific and nonspecific antagonists of this channel have been reported (Holzer, 2004; Clapham et al., 2005) . However, it is difficult to exert an inhibitory effect on the TRPV1-mediated heat-evoked current responses (Tominaga et al., 1998) . In fact, only one chemical, SB-705498, has been reported to completely inhibit heat-evoked TRPV1 responses (Rami et al., 2006) .
We have recently reported that TRPM2 is one of the thermosensitive TRP channels, and is involved in insulin secretion following ligand activation at body temperature (Togashi et al., 2006) . However, there are few membranepermeable TRPM2-specific agonists, which make further research on TRPM2 difficult. Although hydrogen peroxide (H 2 O 2 ) has been known to activate TRPM2 from outside (Hara et al., 2002) , its action on TRPM2 is presumed to be mediated by ADP-ribose (ADPR) production; additionally, H 2 O 2 is known to exhibit various effects on cellular functions. Several chemicals have been reported to act as TRPM2 antagonists. However, they cannot be easily used for experimental purposes. For example, imidazole derivatives, miconazole and clotrimazole, inhibit TRPM2 in an irreversible manner (Hill et al., 2004b) . Another TRPM2 inhibitor, flufenamic acid (FFA), a nonsteroidal anti-inflammatory drug, is not easily dissolved in the aqueous solution, which makes it difficult to prepare a solution containing high concentrations of FFA to inhibit TRPM2 (Hill et al., 2004a) . Furthermore, although N-(p-amylcinnamoyl)anthranilic acid (ACA) is an inhibitor of TRPM2 (Kraft et al., 2006) , it also functions as a phospholipase A 2 inhibitor (Chen et al., 1994) .
2-Aminoethoxydiphenyl borate (2-APB) was first reported as an inositol 1,4,5-trisphosphate (InsP 3 ) receptor antagonist (Maruyama et al., 1997) and is known to inhibit InsP 3 receptor at relatively low concentrations (Bootman et al., 2002) . However, there are several reports proposing that the blocking effects of 2-APB on the increase in intracellular Ca 2 þ levels results from inhibition of plasma membrane, Ca 2 þ -permeable, cation channels by 2-APB rather than that of Ca 2 þ release from InsP 3 -sensitive Ca 2 þ stores (Dobrydneva and Blackmore, 2001; Bootman et al., 2002) . In fact, certain TRPC channels (TRPC1, TRPC3, TRPC5 and TRPC6) and TRPM channels (TRPM3, TRPM7 and TRPM8) have been reported to be inhibited by 2-APB (Ma et al., 2000; Delmas et al., 2002; Hu et al., 2004; Xu et al., 2005; Li et al., 2006) . In contrast, some TRPV channels (TRPV1, TRPV2 and TRPV3) are known to be activated by 2-APB (Chung et al., 2004; Hu et al., 2004) . Here, we have screened several compounds to investigate their potential to activate or inhibit the TRPM2 channels, and we observed that 2-APB exerts a strong inhibitory effect on TRPM2 channels that are activated by its ligand and heat. In addition, we observed that 2-APB inhibited heat-evoked insulin release from the pancreatic islets.
Methods

Preparation of HEK cells
Human embryonic kidney cells (HEK293 cells) were maintained in Dulbecco's modified Eagle's medium (Sigma, St Louis, MO, USA; supplemented with 10% fetal bovine serum, penicillin-streptomycin (Gibco, Carlsbad, CA, USA) and heat-stable L-glutamine analogue, GlutaMAX-I (Gibco)) on a culture dish (f ¼ 10 cm) at 37 1C. We confirmed that no TRPM2 is endogenously expressed in HEK293 cells both in western blotting (data not shown) and patch-clamp recordings (Togashi et al., 2006 In an effort to observe a maximal TRPM2 response to heat, we decided to apply heat ramps approximately 2-3 min after establishing the whole-cell configuration with the pipette solution containing ADPR or cADPR. As the ADPR-evoked currents developed at various time points (approximately 3 min) after establishing the whole-cell configuration, the heat stimuli were applied by increasing the bath temperature at a rate of 1.0 1C s À1 with a preheated solution. When the inactivation of the heat-activated currents began, the temperature of the preheated solution was changed to 25 1C. The chamber temperature was monitored with a thermocouple placed within 100 mm of the patch-clamped cell.
Preparations of pancreatic islets from rats
All procedures involving the care and use of animals were carried out in accordance with institutional (National Institute for Physiological Science) guidelines. Male Wistar rats (9-10 weeks of age; SLC, Shizuoka, Japan) were used. They were housed in a controlled environment (12 h light/ dark cycle, room temperature 22-24 1C, 50-60% relative humidity) with free access to food and water. Rats were deeply anaesthetized with pentobarbital sodium (70 mg kg
À1
) and killed. The common bile duct was cannulated with a 21-gauge needle and the pancreas was distended with 10 ml of Hanks' balanced salt solution (Gibco) containing collagenase. Subsequently, the pancreas was excised and digested in the Hanks' balanced salt solution at 37 1C. The pancreatic islets were purified on HISTOPAQUE-1077 (Sigma) gradients by a method modified from the one described previously (Sutton et al., 1986; Ban et al., 2000; Togashi et al., 2006) . The islets were dispersed in RPMI-1640 medium (with 20% fetal bovine serum, penicillin-streptomycin and GlutaMAX-I); subsequently, they were cultured overnight at 37 1C. Insulin release from the islets was measured following 16-h culture at 37 1C after isolation as previously described (Togashi et al., 2006) . The amount of immunoreactive insulin released was determined by ELISA (Morinaga, Yokohama, Japan). The amount of insulin was normalized to the values released from the islets by glucose (3.3 mM). Groups of islets were incubated in Krebs-Ringer bicarbonate buffer with additives for 60 min. At the end of the incubation TRPM2-inhibition by 2-APB K Togashi et al period, islets were pelleted and aliquots of the buffer were sampled.
Statistical methods
Data are analysed using an unpaired (* or **) or a paired (#) t-test. Values are shown as mean±s.e.mean. P-values o0.05 were considered significant. Materials ADP-ribose sodium salt, cyclic ADPR (cADPR), 2-APB and exendin-4 were purchased from Sigma. Stocks of ADPR and cADPR were dissolved in distilled water at concentration of 10 mM, aliquoted into small fractions and frozen at À80 1C. Each aliquot was freshly thawed and diluted in the pipette solution before starting the experiment. The stock of 2-APB was dissolved in 500 mM dimethyl sulphoxide and stored at À20 1C. The stock of exendin-4 was dissolved in 200 mM phosphate-buffered saline with 0.5% BSA, aliquoted into small fractions and frozen at À80 1C. Before the experiment, each stock solution was diluted in the bath solution or Krebs-Ringer bicarbonate buffer.
Results
We first examined the effects of the previously reported TRPM2 antagonists on the ADPR-activated currents. Because the ADPR-activated TRPM2 currents often exhibit some desensitization ( Figure 1a ) (Togashi et al., 2006) , we applied the antagonists just after starting desensitization, although the time course of the compound-induced inhibition was much faster than that of desensitization. Both miconazole (10 mM) and ACA (20 mM) exhibited complete inhibition of ADPR (100 mM)-evoked TRPM2 responses at À60 mV (Figures 1b and c) . In contrast, FFA did not exert complete inhibition even at its highest available concentration (200 mM; Figure 1d ). We attempted to examine the effects of 2-APB on the TRPM2 currents. ADPR-activated inward currents were inhibited reversibly and rapidly in a dosedependent manner by 2-APB (Figure 1e ), which suggests that the inhibition was not mediated by InsP 3 receptor. In either case, the inhibition was much faster than the desensitization. To examine whether 2-APB-induced inhibition of TRPM2 current is voltage dependent, we examined the effects of 2-APB (100 mM) on the TRPM2 currents at different potentials. The ADPR-activated TRPM2 currents did not change during 100-ms-step pulses, and 2-APB caused partial (at 10 mM) or complete (at 100 mM) inhibition of TRPM2 currents at all the membrane potentials examined (Figure 1f ), indicating that TRPM2 inhibition by 2-APB was voltage independent.
This inhibition of ADPR-evoked TRPM2 currents by 2-APB prompted us to examine the effects of 2-APB on the TRPM2 currents elicited by ADPR with heat. As shown in Figure 2a , 2-APB (100 mM) caused a rapid, complete and reversible inhibition of TRPM2 currents activated by ADPR (100 mM) with heat. Similarly, 2-APB was found to inhibit TRPM2 currents activated by cADPR (100 mM) with heat ( Figure 2b ).
In addition, prolonged heat stimulus resulted in desensitization of TRPM2 currents (Figures 2a and b ) similar to that observed in repetitive heat application reported before (Togashi et al., 2006) . The rapid and complete inhibition of TRPM2 channels with easy washout by 2-APB (Figure 2b , right) suggests that 2-APB acts on TRPM2 from outside. This interpretation was supported by results from other experiments where TRPM2 currents were activated by ADPR using a pipette solution containing 2-APB (30 mM) and inhibited by 2-APB (30 mM) applied from outside (Figure 2c ). Similar IC 50 values for 2-APB-induced inhibition of TRPM2 currents activated by ADPR regardless of heat stimulus (0.82 ± 0.2 mM for with heat and 1.17 ± 0.1 mM for without heat) (Figure 2d ) suggest identical mechanisms for the inhibitory action of 2-APB, despite the differences in the current size and channel properties, with and without the heat stimulus (Togashi et al., 2006) .
Next, we speculated whether this 2-APB-induced inhibition is specific to TRPM2 currents activated by its ligands with heat. Even in the presence of FFA (200 mM), the cADPR with heat could activate TRPM2 channels although the activated currents were significantly smaller than those without inhibitors (Figures 3a and d) . In the presence of ACA (20 mM), slight TRPM2 current activation was observed, and the inhibitory effects lasted even after ACA washout (Figures 3b and d) . In contrast, TRPM2 activation was completely inhibited in the presence of 2-APB, and huge inward currents were elicited by cADPR with heat upon 2-APB washout ( Figures 3c and d) ; this clear washout effect was similar to that observed in the short 2-APB application after TRPM2 activation (Figure 2b ). These results indicate that 2-APB is a good inhibitor to characterize electrophysiological properties of TRPM2.
There is a report showing that 2-APB (75 and 150 mM) had no effect on TRPM2 currents activated by ADPR although the same concentrations were found to inhibit TRPC5, TRPC6 and TRPM3 (Xu et al., 2005) , contradicting our results. They used HEK293 cells having stable tetracycline-regulated expression of cDNA encoding TRPM2, which looks unlikely to explain the difference, and they used a pipette solution containing sodium ATP (5 mM (Figure 4) . Finally, we examined the effects of 2-APB on insulin release from the rat pancreatic islets because we reported that at physiological body temperature, TRPM2 activation is involved in insulin release (Togashi et al., 2006) . Heat stimulus at 40 1C for 5 min caused significant increase in insulin release as previously reported (Figure 5a) (Togashi et al., 2006) and this heat-induced insulin release was almost completely inhibited by 2-APB (100 mM). To examine the 2-APB effects on insulin release under more physiological TRPM2-inhibition by 2-APB K Togashi et al conditions, we applied 2-APB at 37 1C. 2-APB significantly inhibited insulin release (Figure 5b ), thereby suggesting that TRPM2 is involved in insulin release at normal core body temperature as reported earlier (Togashi et al., 2006) . We previously reported that TRPM2-mediated action might be involved in glucagon-like peptide 1 (GLP-1)-induced insulin release that involves cAMP activation downstream of glucagon-like peptide 1 receptor (Togashi et al., 2006) . Therefore, we examined the effects of 2-APB on the insulin release enhanced by exendin-4, a glucagon-like peptide 1 receptor agonist. 2-APB inhibited the exendin-4-enhanced insulin release to the level similar to that caused by 2-APB without exendin-4 (Figure 5b ), suggesting that exendin-4-mediated insulin release involves TRPM2 activation.
Discussion and conclusions
In the present study, we found that 2-APB could reversibly and completely inhibit TRPM2 currents activated by either ligand alone or a combination of ligands with heat at concentrations comparable to those reported for the known TRPM2 inhibitors (Togashi et al., 2006) . In addition, potency of 2-APB to inhibit TRPM2 seems to be higher than those for other channels and proteins (Table 1) . Furthermore, 2-APB could clearly inhibit insulin secretion from isolated pancreatic islets, confirming our recent report that TRPM2 activation at body temperature is involved in insulin secretion (Togashi et al., 2006) . Given that many mechanisms and pathways are known to be involved in insulin secretion, the significant inhibition of insulin release by 
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2-APB observed in our study suggests that a mechanism involving TRPM2 plays an important role in insulin secretion in pancreas. The present study also suggests that we should interpret findings with TRPM2 blockers carefully. As ACA, a TRPM2 and phospholipase A 2 inhibitor, is known to inhibit insulin secretion (Chen et al., 1994) , that secretion would seem to involve both TRPM2 and phospholipase A 2 . It has been reported that 2-APB (75 and 150 mM) exhibited no effects on ADPR-evoked TRPM2 responses at a whole-cell current level (Xu et al., 2005) . To study this phenomenon, we used an identical pipette solution to that used by Xu et al. (2005) , and activated TRPM2 by high concentration of ADPR (500 mM). Even under these conditions, 30 mM 2-APB, a lower concentration than those in the report, was found to inhibit the ADPR-activated TRPM2 currents, almost completely regardless of the presence of cytosolic free Ca 2 þ (Figure 4 ).
Thus, we could not identify the factor(s) responsible for the difference between the two sets of results. Xu et al. (2005) showed no activation process of TRPM2 by ADPR in the experiments examining 2-APB effects, suggesting that some leak components could be present. Alternatively, the tetracycline-regulated expression system with FLAG-epitopetagged TRPM2, as used in their study might influence the effect of 2-APB. Insulin secretion from pancreatic islets was profoundly inhibited by 2-APB, regardless of treatment with exendin-4 (Figure 5b ). This effect might be partly explained by the inhibitory effects of 2-APB on other proteins expressed in pancreas, such as connexins, in addition to its effect on TRPM2. For instance, connexin36-mediated coupling is known to contribute to the coordination and synchronization of the function of individual cells within pancreatic islets, particularly in the context of glucose-induced insulin secretion (Nlend et al., 2006) and 2-APB has been reported to inhibit specific gap junction channel subtypes including connexin36 in the micromolar range (Bai et al., 2006) . Alternatively, IP 3 receptors, K þ channels and other TRP channels, which can be blocked by 2-APB (see Table 1 ), could also be involved in insulin release. Structural comparison of the known TRPM2 inhibitors including 2-APB will provide additional information on the TRPM2-inhibition by 2-APB K Togashi et al structural basis for the TRPM2 gating kinetics. The fact that 2-APB-inhibition of TRPM2 channel is rapid and reversible suggests that 2-APB acts from the outside of the cell membrane. Single-channel analysis will provide us with a more detailed understanding of the mechanism underlying 2-APB inhibition of TRPM2. We conclude that 2-APB is a powerful and effective tool in studying the functions of TRPM2 channels, whose physiological significance can be appreciated in a variety of physiological functions ranging from cell death (Hara et al., 2002) to insulin release.
